| Literature DB >> 34987581 |
Junqiang Liu1, Yiheng Jiang1, Hongwei Huang1, Zheng Zhu2, Jing Chen3, Dikuan Liu1, Lina Wang1, Huafeng Zong4, Xishuang Song1, Xuejian Wang1, Xinqing Zhu1, Jianbo Wang1, Sony Nahayo1, Qiwei Chen1,5, Deyong Yang1.
Abstract
BACKGROUND: To assess the clinical characteristics, radiological predictors, and pathological features of perinephric fat adhesion degree (PFAD) graded based on fixed criteria and to determine the impact of adherent perinephric fat (APF) on retroperitoneal laparoscopic partial nephrectomy (RLPN) outcomes.Entities:
Year: 2021 PMID: 34987581 PMCID: PMC8723850 DOI: 10.1155/2021/9095469
Source DB: PubMed Journal: J Oncol ISSN: 1687-8450 Impact factor: 4.375
Figure 1Surgical criterion of APF. (a) Normal perinephric fat (NPF). (b) Mild adherent perinephric fat (MiPF). (c) Moderate adherent perinephric fat (MoPF). (d) Severe adherent perinephric fat (SPF).
Figure 2Measurement of perinephric fat at the level of the vein. M, medial perinephric fat thickness; L, lateral perinephric fat thickness; P, posterior perinephric fat thickness; PL, posterolateral perinephric fat thickness; circle, HU of perinephric fat; triangle, stranding; RV, renal vein.
Clinical and radiographic characteristics stratified by adhesiveness of perinephric fat.
| Characteristics | NPF ( | MiPF ( | MoPF ( | SPF ( | Total ( |
|---|---|---|---|---|---|
| Age (y) | |||||
| ≤55 | 12 (60) | 13 (46) | 7 (39) | 4 (22) | 36 (43) |
| >55 | 8 (40) | 15 (54) | 11 (61) | 14 (78) | 48 (57) |
| Male gender (%) | 6 (30) | 14 (50) | 15 (83.3) | 17 (94.4) | 52 (61.9) |
| BMI, kg/m2 (%) | |||||
| ≤25 | 8 (40) | 15 (53.6) | 6 (33.3) | 4 (22.2) | 33 (39.3) |
| 25–30 | 10 (50) | 9 (32.1) | 10 (55.6) | 9 (50) | 38 (45.2) |
| ≥30 | 2 (10) | 4 (14.3) | 2 (11.1) | 5 (27.8) | 13 (15.5) |
| Diabetes (%) | 5 (25) | 6 (21.4) | 4 (22.2) | 6 (33.3) | 19 (22.6) |
| Hypertension (%) | 5 (25) | 12 (42.9) | 9 (50) | 12 (66.7) | 38 (45.2) |
| Cardiovascular disease (%) | 3 (15) | 2 (7.1) | 3 (16.7) | 2 (11.1) | 10 (11.9) |
| Preoperative eGFR (<60 ml/min) (%) | 0 (0) | 0 (0) | 0 (0) | 2 (11.1) | 2 (2.4) |
| Active smoking (%) | 7 (35) | 9 (32.1) | 7 (38.9) | 8 (44.4) | 31 (36.9) |
| Alcoholism (%) | 7 (35) | 11 (39.3) | 6 (33.3) | 8 (44.4) | 32 (38.1) |
| Malignancy (%) | 10 (50) | 16 (57.1) | 12 (66.7) | 14 (77.8) | 52 (61.9) |
| Preoperative creatinine (>ULN) (%) | 4 (20) | 3 (10.7) | 3 (16.7) | 4 (22.2) | 14 (16.7) |
| HU of perinephric fat | −103 (−106.6, −99.3) | −101 (−107.8, −96.3) | −95 (−106.6, −94.2) | −88 (−98.1, −81.5) | −98 (−106.5, −93) |
| Perinephric fat area (cm2) | 0.69 (0.5, 1.3) | 2.81 (1.8, 3.3) | 5.44 (4.5, 7.1) | 8.61 (6.2, 12.0) | 3.05 (1.6, 6.2) |
| Perinephric fat thickness (mm) | |||||
| Medial | 1 (0, 3.5) | 5.9 (3.8, 7.7) | 7.5 (4.9, 10.6) | 9.6 (6.8, 17.2) | 5.8 (3.1, 9.2) |
| Lateral | 1.1 (0, 6.3) | 10.1 (4.9, 15.0) | 17.5 (12.2, 23.8) | 22.5 (8.9, 25.3) | 11.2 (4.3, 20.1) |
| Posterior | 3.5 (2.3, 5.3) | 7.8 (6.0, 11.8) | 12.7 (8.7, 16.1) | 19.4 (16.2, 31.4) | 9.7 (5.7, 15.8) |
| Posterolateral | 8.8 (5.7, 11.8) | 13.8 (9.0, 16.9) | 15.7 (14.0, 20.8) | 24 (19.0, 29.6) | 15.1 (10.2, 22.3) |
| Stranding (%) | |||||
| None | 20 (100) | 26 (92.8) | 6 (33.3) | 0 (0) | 52 (61.9) |
| Type 1 | 0 (0) | 2 (7.2) | 11 (61.1) | 11 (61.1) | 24 (28.6) |
| Type 2 | 0 (0) | 0 (0) | 1 (5.6) | 7 (39.9) | 52 (9.5) |
Univariate and multivariable analyses clinical characteristics of PFAD.
| Characteristics | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR |
| OR |
| |
| Age | 2.61 (1.17, 5.82) |
| 3.76 (1.57, 8.97) |
|
| Male gender | 8.39 (3.32, 21.24) |
| 13.14 (4.87, 35.46) |
|
| BMI | ||||
| ≥30 | 2.65 (0.82, 8.54) | 0.103 | ||
| 25–30 | 1.58 (0.68, 3.68) | 0.375 | ||
| Diabetes | 1.83 (0.73, 4.62) | 0.200 | ||
| Hypertension | 2.85 (1.28, 6.33) |
| 3.28 (1.40, 7.65) |
|
| Cardiovascular disease | 0.99 (0.30, 3.25) | 0.988 | ||
| Active smoking | 1.34 (0.60, 298) | 0.475 | ||
| Alcoholism | 1.18 (0.53, 2.60) | 0.685 | ||
| Malignancy | 2.14 (0.95, 4.80) | 0.065 | ||
| Preoperative creatinine | 0.84 (0.30, 2.37) | 0.747 | ||
Bold values indicate significantly correlated factors.
Univariate and multivariable analyses of predicting factors of PFAD.
| Characteristics | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR |
| OR |
| |
| Perinephric fat thickness | ||||
| Medial | 12.48 (4.79, 32.55) |
| ||
| Lateral | 3.18 (2.01, 5.04) |
| ||
| Posterior | 31.09 (10.62, 91.02) |
| 11.46 (1.86, 70.60) |
|
| Posterolateral | 6.68 (3.43, 13.01) |
| ||
| Perinephric fat area | 1.91 (1.55, 2.35) |
| ||
| HU of perinephric fat | 1.14 (1.08, 1.20) |
| 1.08 (1.01, 1.14) |
|
| Stranding | ||||
| Type 1 | 113.44 (21.08, 610.32) |
| 25.05 (3.76, 167.00) |
|
| Type 2 | 986.26 (68.87, 14123.33) |
| 35.21 (1.32, 937.66) |
|
Bold values indicate significantly correlated factors.
Correlation between APF and perioperative outcomes and pathological grading of RCC.
| Variable | APF | Control group with no APF |
|
|---|---|---|---|
| Operative time (OT) (min) | 110.50 (70.8, 126.0) | 89 (85.3, 141.5) | 0.141 |
| Warm ischemia time (WIT) (min) | 20.50 (17.8, 32.0) | 21 (18.8, 25.3) | 0.986 |
| Drain output (ml) | 169 (121.8, 186.3) | 125.5 (94.5, 155.0) |
|
| Postoperative gastrointestinal recovery time (days) | 5 (2.8, 6.0) | 4 (3.0, 5.0) | 0.611 |
| Length of stay (days) | 15 (13.8, 18.3) | 14 (12.8, 15.3) | 0.091 |
| Transfusions | 2 (5.6%) | 3 (6.3%) | 0.894 |
| Estimated blood loss (EBL) (ml) | 240 (195.5, 282.0) | 215 (171.5, 270.8) | 0.249 |
| Postoperative fever (>38.0°C) | 1 (2.8%) | 4 (8.3%) | 0.287 |
| Postoperative gastrointestine discomfort | 11 (30.6%) | 10 (20.8%) | 0.309 |
| Change dressing frequency | 4.5 (3.0, 6.3) | 3 (2.0, 5.0) | 0.052 |
| Clavien–Dindo classification (CDC) | 18 (50%) | 18 (37.5%) | 0.265 |
| Clavien 1 | 15 (41.7%) | 15 (31.3%) | |
| Clavien 2 | 3 (8.3%) | 3 (6.3%) | |
| Fuhrman grade | 26 (72%) | 26 (54%) | 0.106 |
| I | 10 (27.8%) | 10 (20.8%) | |
| II | 10 (27.8%) | 11 (22.9%) | |
| III | 2 (5.6%) | 4 (8.3%) | |
| IV | 4 (11.1%) | 1 (2.1%) |
Bold values indicate significant difference.
Figure 3Representative examples of Masson, CD45, and CD34 staining. (a) Non-APF group having a thin extracapsular fascia, APF group renal capsule, and extracapsular fascia fusion thickening. (b) APF CD45 immune cells in the group highly expressed in the renal capsule and adjacent renal cortex. (c) APF group CD34 for vascular staining. Scale bar = 100 mm.
Summary of previous studies on APF.
| Author (year) | Patient | Surgery | APF grading | APF rate (%) | Included factors | Significant variables |
|---|---|---|---|---|---|---|
| Bylund et al. (2013) | 29 | RPN, OPN, or laparoscopic cryoablation | Operative records | 55.2 | Clinical, imaging, pathological, outcome | Male gender, tumor size, stranding, tumor >50% exophytic, thickness of perinephric fat, and OT |
| Zheng et al. (2014) | 41 | OPN | Time of perinephric fat dissection on | 53.7 | Clinical, imaging, pathological, outcome | Male gender and PnFSD |
| Davidiuk et al. (2014) | 100 | RPN | Described by Kim et al. | 30 | Clinical, imaging, pathological, outcome | Male gender, BMI, posterolateral and posterior perinephric fat, and stranding |
| Davidiuk et al. (2015) | 100 | RPN | Described by Kim et al. | 30 | Outcome | |
| Kobayashi et al. (2016) | 47 | LPN or RALPN | Operative records | 14.9 | Clinical, imaging, outcome | OT, hypertension, and FSPA on CT |
| Martin et al. (2016) | 86 | OPN | Operative records | 50.0 | Clinical, imaging, outcome | Age and MAP score |
| Kocher et al. (2016) | 245 | LPN or RPN | Operative records | 10.6 | Clinical, imaging, pathological, outcome | Age, male gender, stranding, posterior fat thickness, MAP score, malignant renal histology, operating time, and EBL |
| Dariane et al. (2016) | 125 | RPN or OPN | Described by Kim et al. | 40.8 | Clinical, imaging, pathological, outcome, histological | OT, EBL, male gender, age, waist circumference, fat density on CT, MAP score, and larger adipocytes |
| Shintaro et al. (2017) | 92 | Laparoscopic donor nephrectomy | Intraoperative videos | 55.4 | Clinical, imaging, outcome, IHC | Perinephric fat area, stranding, sIL-6R, and OT |
| Khene et al. (2017) | 202 | RPN | Operative records | 39.6 | Clinical, imaging, outcome | Male gender, obesity, hypertension, MAP score, OT, EBL, transfusion, and conversion to open surgery or radical nephrectomy |